key: cord-1029260-rin2ahz9 authors: Schondelmeyer, Amanda C.; Bettencourt, Amanda P.; Xiao, Rui; Beidas, Rinad S.; Wolk, Courtney Benjamin; Landrigan, Christopher P.; Brady, Patrick W.; Brent, Canita R.; Parthasarathy, Padmavathy; Kern-Goldberger, Andrew S.; Sergay, Nathaniel; Lee, Vivian; Russell, Christopher J.; Prasto, Julianne; Zaman, Sarah; McQuistion, Kaitlyn; Lucey, Kate; Solomon, Courtney; Garcia, Mayra; Bonafide, Christopher P. title: Evaluation of an Educational Outreach and Audit and Feedback Program to Reduce Continuous Pulse Oximetry Use in Hospitalized Infants With Stable Bronchiolitis: A Nonrandomized Clinical Trial date: 2021-09-02 journal: JAMA Netw Open DOI: 10.1001/jamanetworkopen.2021.22826 sha: 0f343d391eb197285edbb7a81bb4c0c3672d3c21 doc_id: 1029260 cord_uid: rin2ahz9 IMPORTANCE: National guidelines recommend against continuous pulse oximetry use for hospitalized children with bronchiolitis who are not receiving supplemental oxygen, yet guideline-discordant use remains high. OBJECTIVES: To evaluate deimplementation outcomes of educational outreach and audit and feedback strategies aiming to reduce guideline-discordant continuous pulse oximetry use in children hospitalized with bronchiolitis who are not receiving supplemental oxygen. DESIGN, SETTING, AND PARTICIPANTS: A nonrandomized clinical single-group deimplementation trial was conducted in 14 non–intensive care units in 5 freestanding children’s hospitals and 1 community hospital from December 1, 2019, through March 14, 2020, among 847 nurses and physicians caring for hospitalized children with bronchiolitis who were not receiving supplemental oxygen. INTERVENTIONS: Educational outreach focused on communicating details of the existing guidelines and evidence. Audit and feedback strategies included 2 formats: (1) weekly aggregate data feedback to multidisciplinary teams with review of unit-level and hospital-level use of continuous pulse oximetry, and (2) real-time 1:1 feedback to clinicians when guideline-discordant continuous pulse oximetry use was discovered during in-person data audits. MAIN OUTCOMES AND MEASURES: Clinician ratings of acceptability, appropriateness, feasibility, and perceived safety were assessed using a questionnaire. Guideline-discordant continuous pulse oximetry use in hospitalized children was measured using direct observation of a convenience sample of patients with bronchiolitis who were not receiving supplemental oxygen. RESULTS: A total of 847 of 1193 eligible clinicians (695 women [82.1%]) responded to a Likert scale-based questionnaire (71% response rate). Most respondents rated the deimplementation strategies of education and audit and feedback as acceptable (education, 435 of 474 [92%]; audit and feedback, 615 of 664 [93%]), appropriate (education, 457 of 474 [96%]; audit and feedback, 622 of 664 [94%]), feasible (education, 424 of 474 [89%]; audit and feedback, 557 of 664 [84%]), and safe (803 of 847 [95%]). Sites collected 1051 audit observations (range, 47-403 per site) on 709 unique patient admissions (range, 31-251 per site) during a 3.5-month period of continuous pulse oximetry use in children with bronchiolitis not receiving supplemental oxygen, which were compared with 579 observations (range, 57-154 per site) from the same hospitals during the baseline 4-month period (prior season) to determine whether the strategies were associated with a reduction in use. Sites conducted 148 in-person educational outreach and aggregate data feedback sessions and provided real-time 1:1 feedback 171 of 236 times (72% of the time when guideline-discordant monitoring was identified). Adjusted for age, gestational age, time since weaning from supplemental oxygen, and other characteristics, guideline-discordant continuous pulse oximetry use decreased from 53% (95% CI, 49%-57%) to 23% (95% CI, 20%-25%) (P < .001) during the intervention period. There were no adverse events attributable to reduced monitoring. CONCLUSIONS AND RELEVANCE: In this nonrandomized clinical trial, educational outreach and audit and feedback deimplementation strategies for guideline-discordant continuous pulse oximetry use among hospitalized children with bronchiolitis who were not receiving supplemental oxygen were positively associated with clinician perceptions of feasibility, acceptability, appropriateness, and safety. Evaluating the sustainability of deimplementation beyond the intervention period is an essential next step. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04178941 The study aimed to include exclusively patients for whom continuous pulse oximetry is not indicated In this study that included over 3600 in-person assessments of pulse oximetry monitoring status, we 242 found that the overall monitoring rate across all hospitals was 46%, with a very wide range of 243 variation, ranging from hospitals that monitor <5% of these patients to hospitals that monitor >85% of The investigators will perform the study in accordance with this protocol and will report unanticipated 269 problems involving risks to subjects or others in accordance with Children's Hospital of Philadelphia The primary objective of this study is to measure the feasibility, acceptability, and appropriateness of • In hospitals with "medical device integration" in which data from physiologic monitors are sent 284 directly to the electronic health records, we will: • Validate that the medical device integration data in the electronic health record reflects the 286 findings of direct in-person observation described above as the gold standard. • Recruitment: The audit and feedback intervention will be delivered to the same health care 304 professionals who are involved in the decisions or actions surrounding the initiation or 305 discontinuation of continuous pulse oximetry monitoring in usual care. • Setting: The pilot is being performed in hospital settings that are identical to the types of 307 settings where we intend the results to be applied. • Organization: Given the highly pragmatic nature of this study, the intervention will be 309 delivered into each hospital using the same structures of care used locally for making 310 improvements in bronchiolitis care delivery. • Flexibility in intervention delivery: Consistent with the idea that interventions can be tailored 312 to local context, we will allow for flexibility/adaptation/tailoring in the content and format of 313 the educational materials and outreach sessions. Thus, the methodology of exactly how to 314 deliver this intervention is not rigidly prescriptive in this protocol. In addition, it is possible that 315 some sites will be performing concurrent quality improvement interventions targeting pulse 316 oximetry overuse. We will seek to fully understand when and how any potential quality 317 improvement interventions interact with this study but we will not restrict sites from 318 performing separate improvement initiatives nor will we will regulate or oversee their 319 concurrent quality improvement projects. • Flexibility in adherence to the intervention: While we will monitor health care professionals' The intervention period will last between 2-4 months depending on the timing relative to the local 328 epidemiology-dictated bronchiolitis season. The primary subjects are hospital staff. Secondary subjects are patients age 2 through 23 months 330 with a primary diagnosis of bronchiolitis. The study will be conducted in up to 10 hospitals in the United States. accurately measure the actual number of staff whose behavior could potentially have been impacted 340 by the intervention. It also will not be possible to identify when hospital staff are exposed to the 6 involvement of 100 hospital staff per unit during the entire intervention period. Based on an average 343 of 5 available units per hospital in candidate hospitals, we can estimate 10 hospitals * 5 units per 344 hospital * 100 staff per unit = 5,000 hospital staff subjects, acknowledging that this number will not 345 be completely accurate but is a reasonable estimate. When we report the "actual" number of primary 346 exposed subjects involved for continuing reviews and study closure, we will report 100 * the total 347 number of units involved in the study. Primary subjects completing the questionnaires (hospital staff): We will aim for 100 completed 349 questionnaires per hospital x 10 hospitals = 1,000 primary subjects completing the questionnaires. Since these 1,000 will be drawn from within the 5,000 listed above, they will not add to the overall 351 subject total. • Implementation champions identified, local teams formed • Local team members will meet with leadership on each potential unit; unit leadership will be 385 given the opportunity to opt their unit out of the study for any reason. • On a weekly basis, the data will be summarized in a dashboard and the dashboard along 405 with the raw data will be returned to the site PI. • Local implementation team will then share that data in electronic and in-person settings We will generate average scores for each item and for each measure, stratified by hospital and role 554 (e.g. nurse, physician). Data from chart review will be extracted from the medical record system used at the hospital site. This may include electronic medical records (e.g. the Epic system at CHOP) or paper medical 593 records. All data and records generated during this study will be kept confidential in accordance with Institutional policies and HIPAA on subject privacy. The Investigator and other site personnel will not 602 use such data and records for any purpose other than conducting the study. The only PHI elements that documented in the study database are the admission date and the date 604 the data collection rounds occurred (which by definition is a date during the patient's hospitalization). Thus this is a limited dataset. The dataset is also coded to decrease the risk of breach of confidentiality. A patient-admission ID 607 number not otherwise associated with the individual (not derived from any element of PHI) will be 608 generated by each site and included in the study database allowing patients to be followed over time 13 cabinet and destroyed after abstraction into REDCap. Handling of the master list is described in the 634 above section. After data collection, exported data for analysis will take place only on computers that meet CHOP IT 636 standards for encryption and password protection as outlined in CHOP IT SOP A-3-6. Data will be 637 stored on the CHOP research SAN and/or other secure servers maintained by CHOP IT. Only 638 investigators and study staff approved by the IRB will have access to data containing PHI. In accordance with the current CHOP Retention of Records Policy A-3-9 in the Administrative Policy Manual, section on minimal risk human subjects research records, we will retain all information from 641 this study for 6 years after the study is completed, after which PHI will be stripped from the data set. We recognize that other sites relying on the CHOP IRB have different record retention requirements. from the procedures outlined above. Risks are not greater than minimal in this study. The primary risk is breach of privacy and 688 confidentiality. Less likely are threats to patient safety. These risks will be minimized as described The pragmatic approach to recruitment of health care professionals and patients for the intervention 717 has been described in previous sections. For the data collection in-person observational rounds, site investigators will identify all patients 719 currently admitted to their hospital's non-ICU pediatric wards with bronchiolitis by reviewing the 720 census of each unit that cares for children with bronchiolitis and examining the charts of patients The first section of the questionnaire will include the required elements of consent and a statement The research meets the criteria of 45 CFR 46.116(d), as illustrated below: (1) Risks are not greater than minimal in this study. The primary risk is breach of privacy and 766 confidentiality. The risk will be minimized by keeping all data and records confidential in 767 accordance with institutional policies on subject privacy. The investigators will not use data or 768 records for any purpose other than conducting the study. Please see Section 8.3 for additional 769 details. (2) The waiver or alteration will not adversely affect the rights and welfare of the subjects because 771 PHI will only be accessed by IRB approved study staff performing data collection, and we are 772 collecting a limited, coded dataset to minimize risk of PHI exposure. (3) The research could not practicably be carried out without the waiver or alteration. The intent is to 774 obtain a large, unbiased sample of patients with bronchiolitis to obtain insights on hospital-level 775 practices and systems of care related to pulse oximetry monitoring in bronchiolitis. The research 16 locate and contact the families of all of the patients whose clinical records will be required in 778 order for this to be an unbiased sample representative of the population with adequate sample 779 size. If we fail to obtain all of the data due to families who cannot be located/contacted, this will 780 threaten the statistical outcome, bias the sample, prohibit conclusions to be drawn or alter the 781 sample such that conclusions would be skewed. (4) There will not be any pertinent patient-level information that would benefit the patient directly 783 after participation so none of the subjects will be provided with additional information after 784 participation. (1) An adequate plan to protect the identifiers from improper use and disclosure; • We have provided an adequate plan to protect identifiers from improper 795 use and disclosure above. (2) An adequate plan to destroy the identifiers at the earliest opportunity consistent (3) Adequate written assurances that the protected health information will not be 804 reused or disclosed to any other person or entity, except as required by law, for Peer-reviewed publication is planned. No identifiable information will be used in publication. Effect of pulse oximetry, age, and ASA physical status 835 on the frequency of patients admitted unexpectedly to a postoperative intensive care unit and the severity of their 836 anesthesia-related complications The impact of continuous pulse oximetry monitoring on intensive care 838 unit admissions from a postsurgical care floor Use of intermittent vs continuous pulse oximetry for nonhypoxemic infants and 841 young children hospitalized for bronchiolitis: a randomized clinical trial Effect of oximetry on hospitalization in bronchiolitis: a randomized clinical trial Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-846 blind, randomised, equivalence trial Effect of oxygen desaturations on subsequent 848 medical visits in infants discharged from the emergency department with bronchiolitis Using quality improvement to reduce continuous pulse oximetry 851 use in children with wheezing Impact of pulse oximetry and oxygen therapy on length of stay in 853 bronchiolitis hospitalizations Observational study of two oxygen saturation targets for discharge in bronchiolitis. Arch 19. Oxygen Saturation Monitoring in Bronchiolitis -ClinicalTrials Bronchiolitis RCTs at The Hospital for Sick Children Measuring overuse of continuous pulse oximetry in bronchiolitis and 879 developing strategies for large-scale deimplementation: study protocol for a feasibility trial ACC/AHA special report: Clinical practice guideline implementation 882 strategies: A summary of systematic reviews by the NHLBI Implementation Science Work Group: A report of the 883 American College of Cardiology/American Heart Association Task Force on clinical practice guidelines The PRECIS-2 tool: designing trials that are 886 fit for purpose Safety huddle intervention for reducing physiologic monitor alarms: A hybrid 888 effectiveness-implementation cluster randomized trial Impact of a safety huddle-based intervention on monitor alarm rates in low-acuity 890 pediatric intensive care unit patients Psychometric assessment of three newly developed implementation outcome 892 measures Ecological momentary assessment Research electronic data capture (REDCap)-a 895 metadata-driven methodology and workflow process for providing translational research informatics support Reporting and design elements of audit and feedback interventions: a